Stage IV
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment (NCT04263090) | Icahn School of Medicine at Mount Sinai | 2020-06-29 |
| Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC (NCT03965468) | ETOP IBCSG Partners Foundation | 2019-11-19 |
| Aggressive Thoracic Radiotherapy for Stage Ⅳ Non Small Cell Lung Cancer (NCT03565120) | yu gengsheng | 2018-12-10 |
| Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC (NCT00510107) | Gachon University Gil Medical Center | 2007-07-01 |
Track Stage IV automatically
Every clearance here is in the API, with alerts when new ones post.